fluoxetine has been researched along with vasoactive intestinal peptide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, ZH; Huang, YL; Wang, GH; Wang, Q; Xiao, L; Yu, JP | 1 |
| Duncan, MJ; Franklin, KM; Hester, JM; Hopper, JA | 1 |
2 other study(ies) available for fluoxetine and vasoactive intestinal peptide
| Article | Year |
|---|---|
Effect of fluoxetine on depression-induced changes in the expression of vasoactive intestinal polypeptide and corticotrophin releasing factor in rat duodenum.
Topics: Adrenocorticotropic Hormone; Animals; Depression; Duodenum; Fluoxetine; Male; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Vasoactive Intestinal Peptide | 2007 |
The effects of aging and chronic fluoxetine treatment on circadian rhythms and suprachiasmatic nucleus expression of neuropeptide genes and 5-HT1B receptors.
Topics: Aging; Animals; Circadian Rhythm; Cricetinae; Fluoxetine; Gastrin-Releasing Peptide; Male; Motor Activity; Neuropeptides; Photoperiod; Receptor, Serotonin, 5-HT1B; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Suprachiasmatic Nucleus; Vasoactive Intestinal Peptide | 2010 |